Results 171 to 180 of about 10,923 (183)

Islet amyloid polypeptide (amylin): no evidence of an abnormal precursor sequence in 25 Type 2 (non-insulin-dependent) diabetic patients

Diabetologia, 1990
Bell G I, Steiner D F, D F Steiner
exaly  

ISLET AMYLOID FORMED FROM DIABETES-ASSOCIATED PEPTIDE MAY BE PATHOGENIC IN TYPE-2 DIABETES

Lancet, The, 1987
C E Lewis, J F Morris, A C Willis
exaly  

Islet amyloid polypeptide amide causes peripheral insulin resistance in vivo in dogs

Diabetologia, 1990
T Sänke, Furuta H, Nishimura S
exaly  

Dual role of interleukin‐1β in islet amyloid formation and its β‐cell toxicity: I mplications for type 2 diabetes and islet transplantation

Diabetes, Obesity and Metabolism, 2017
Lucy Marzban, Nooshin Safikhan, Timothy Kieffer   +2 more
exaly  

The effect of apolipoprotein E deficiency on islet amyloid deposition in human islet amyloid polypeptide transgenic mice

Diabetologia, 2003
Bruce Verchere, Cnop M, Hull R
exaly  

Altered islet amyloid polypeptide (amylin) gene expression in rat models of diabetes

Diabetologia, 1989
S I Girgis, D Bretherton-Watt, Legon S
exaly  

Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in Type 2 (non-insulin-dependent) diabetic patients

Diabetologia, 1991
T Hanabusa, T Sänke, Nishimura S
exaly  

Islet amyloid: a complication of islet dysfunction or an aetiological factor in Type 2 diabetes?

Diabetologia, 2004
exaly  

Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties

Journal of Molecular Biology, 2000
Aphrodite Kapurniotu, Wolfgang Fischle, Jürgen Bernhagen   +2 more
exaly  

Inhibition of glycosaminoglycan synthesis and protein glycosylation with WAS-406 and azaserine result in reduced islet amyloid formation in vitro

American Journal of Physiology - Cell Physiology, 2007
Steven Kahn, Rebecca L Hull-Meichle, Thomas N Wight   +2 more
exaly